N. Baindur

发表

Development of a high affinity and stereoselective photoaffinity label for the D-1 dopamine receptor: synthesis and resolution of 7-[125I]iodo-8-hydroxy-3-methyl-1-(4'-azidophenyl)-2,3,4,5-tetrahydro- 1H-3-benzazepine.

P. Seeman, H. Niznik, J. Yuan, 1990, Journal of medicinal chemistry.

Potent 2'-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents.

W. Cheung, R. Patch, M. Player, 2007, Bioorganic & medicinal chemistry letters.

L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.

R. Kass, D. Triggle, N. Baindur, 1994, Molecular Pharmacology.

Stereoisomeric, Photoaffinity, Affinity and Fluorescent Probes for Characterization of Dopamine D1 and D2 Receptors

R. Baldessarini, J. Neumeyer, Y. Gao, 1992 .

Selective probes for characterization of dopamine D1 and D2 receptors

R. Baldessarini, J. Neumeyer, B. Madras, 1992, Neurochemistry International.

Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.

R. Baldessarini, J. Neumeyer, N. Kula, 1992, Journal of medicinal chemistry.

A photoaffinity label for the D-1 dopamine receptor, (RS)-7-[125I]Iodo-8-hydroxy-3-methyl-1-(4'-azidophenyl)-2,3,4,5- tetrahydro-1H-3-benzazepine, selectively identifies the ligand binding subunits of the receptor.

P. Seeman, H. Niznik, J. Neumeyer, 1988, Journal of medicinal chemistry.

Solution-Phase Synthesis of a Library of 3,5,7-Trisubstituted 3H-[1,2,3]triazolo[4,5-d]pyrimidines

M. Player, N. Baindur, and Naresh Chadha, 2003 .

Solid-phase synthesis of an oxalic acid amide library.

M. Player, N. Baindur, T. Georgiadis, 2004, Journal of combinatorial chemistry.

Photoaffinity labeling of dopamine D1 receptors.

P. Seeman, H. Niznik, J. Neumeyer, 1988, Biochemistry.

Concepts and progress in the development and utilization of receptor‐specific fluorescent ligands

D. Triggle, N. Baindur, 1994, Medicinal research reviews.

Selective fluorescent ligands for pharmacological receptors

D. Triggle, N. Baindur, 1994 .

2-Hydroxy-4,6-diamino-[1,3,5]triazines: a novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors.

R. Patch, M. Player, T. Carver, 2005, Journal of medicinal chemistry.

(+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.

P. Seeman, H. Niznik, J. Neumeyer, 1991, Journal of medicinal chemistry.

4,6-diaminosubstitues-2-[oxy or aminoxy]-[1,3,5]triazines utilises en tant qu'inhibiteurs de la proteine tyrosine kinase

M. Player, D. Asgari, N. Baindur, 2003 .

A homologous series of permanently charged 1,4-dihydropyridines: novel probes designed to localize drug binding sites on ion channels.

D. Triggle, N. Baindur, A. Rutledge, 1993, Journal of medicinal chemistry.